{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:12:49Z","timestamp":1790190769420,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,5,26]],"date-time":"2013-05-26T00:00:00Z","timestamp":1369526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s10072-013-1460-3","type":"journal-article","created":{"date-parts":[[2013,5,25]],"date-time":"2013-05-25T05:44:48Z","timestamp":1369460688000},"page":"29-34","source":"Crossref","is-referenced-by-count":27,"title":["Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis"],"prefix":"10.1007","volume":"35","author":[{"given":"Y.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. K.","family":"Rauniyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. F.","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,26]]},"reference":[{"issue":"11","key":"1460_CR1","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","volume":"116","author":"BM Conti-Fine","year":"2006","unstructured":"Conti-Fine BM, Milani M, Kaminski HJ (2006) Myasthenia gravis: past, present, and future. J Clin Invest 116(11):2843\u20132854","journal-title":"J Clin Invest"},{"key":"1460_CR2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1196\/annals.1405.042","volume":"1132","author":"BM Conti-Fine","year":"2008","unstructured":"Conti-Fine BM, Milani M, Wang W (2008) CD4+ T cells and cytokines in the pathogenesis of acquired myasthenia gravis. Ann N Y Acad Sci 1132:193\u2013209","journal-title":"Ann N Y Acad Sci"},{"key":"1460_CR3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/35040504","volume":"408","author":"J Parrish-Novak","year":"2000","unstructured":"Parrish-Novak J, Dillon SR, Nelson A et al (2000) Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408:57\u201363","journal-title":"Nature"},{"key":"1460_CR4","doi-asserted-by":"crossref","first-page":"25291","DOI":"10.1074\/jbc.M501459200","volume":"280","author":"HP Kim","year":"2005","unstructured":"Kim HP, Korn LL, Gamero AM et al (2005) Calcium-dependent activation of interleukin-21 gene expression in T cells. J Biol Chem 280:25291\u201325297","journal-title":"J Biol Chem"},{"key":"1460_CR5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.immunol.26.021607.090316","volume":"26","author":"R Spolski","year":"2008","unstructured":"Spolski R, Leonard WJ (2008) Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol 26:57\u201379","journal-title":"Annu Rev Immunol"},{"key":"1460_CR6","doi-asserted-by":"crossref","first-page":"11439","DOI":"10.1073\/pnas.200360997","volume":"97","author":"K Ozaki","year":"2000","unstructured":"Ozaki K, Kikly K, Michalovich D et al (2000) Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci USA 97:11439\u201311444","journal-title":"Proc Natl Acad Sci USA"},{"key":"1460_CR7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.expneurol.2007.11.004","volume":"211","author":"R Liu","year":"2008","unstructured":"Liu R, Bai Y, Vollmer TL et al (2008) IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis. Exp Neurol 211:14\u201324","journal-title":"Exp Neurol"},{"issue":"5","key":"1460_CR8","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.4049\/jimmunol.174.5.2696","volume":"174","author":"TL Vollmer","year":"2005","unstructured":"Vollmer TL, Liu R, Price M et al (2005) Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J Immunol 174(5):2696\u20132701","journal-title":"J Immunol"},{"key":"1460_CR9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10875-012-9780-2","volume":"33","author":"TM Kasahara","year":"2013","unstructured":"Kasahara TM, Teixeira B, Ferreira TB et al (2013) The ex vivo production of IL-6 and IL-21 by CD4(+) T cells is directly associated with neurological disability in neuromyelitis optica patients. J Clin Immunol 33:179\u2013189","journal-title":"J Clin Immunol"},{"key":"1460_CR10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/310244a0","volume":"310","author":"R Hohlfeld","year":"1984","unstructured":"Hohlfeld R, Toyka KV, Heininger K (1984) Autoimmune human T lymphocyte specific for acetylcholine receptor. Nature 310:244\u2013246","journal-title":"Nature"},{"issue":"11","key":"1460_CR11","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.4049\/jimmunol.178.11.7072","volume":"178","author":"W Wang","year":"2007","unstructured":"Wang W, Milani M, Ostlie N et al (2007) C57BL\/6 mice genetically deficient in IL-12\/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells. J Immunol 178(11):7072\u20137080","journal-title":"J Immunol"},{"issue":"3","key":"1460_CR12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00011-009-0087-6","volume":"59","author":"H Yang","year":"2010","unstructured":"Yang H, Zhang Y, Wu M et al (2010) Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dendritic cells\u00a0is associated with a change from a T helper Th17\/Th1 to a Th2 and FoxP3\u00a0+\u00a0regulatory T-cell profile. Inflamm Res 59(3):197\u2013205","journal-title":"Inflamm Res"},{"issue":"1\u20132","key":"1460_CR13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2010.03.016","volume":"225","author":"M Masuda","year":"2010","unstructured":"Masuda M, Matsumoto M, Tanaka S et al (2010) Clinical implication of peripheral CD4+\u00a0CD25+\u00a0regulatory T cells and Th17 cells in myasthenia gravis patients. J Neuroimmunol 225(1\u20132):123\u2013131","journal-title":"J Neuroimmunol"},{"issue":"9","key":"1460_CR14","first-page":"958","volume":"35","author":"B Hu","year":"2010","unstructured":"Hu B, Tian X, Huang H et al (2010) Expression of IL-21 in the peripheral blood of myasthenia gravis patients and its correlation with anti-AChR-Ab class switch. Zhong Nan Da Xue Xue Bao Yi Xue Ban 35(9):958\u2013963 Chinese","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"1\u20132","key":"1460_CR15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jneuroim.2007.12.008","volume":"195","author":"Y Furukawa","year":"2008","unstructured":"Furukawa Y, Yoshikawa H, Iwasa K et al (2008) Clinical efficacy and cytokine network-modulating effects of tacrolimus in myasthenia gravis. J Neuroimmunol 195(1\u20132):108\u2013115","journal-title":"J Neuroimmunol"},{"issue":"3","key":"1460_CR16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.coi.2008.02.004","volume":"20","author":"R Spolski","year":"2008","unstructured":"Spolski R, Leonard WJ (2008) The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer. Curr Opin Immunol 20(3):295\u2013301","journal-title":"Curr Opin Immunol"},{"key":"1460_CR17","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.4049\/jimmunol.173.9.5361","volume":"173","author":"K Ozaki","year":"2004","unstructured":"Ozaki K, Spolski R, Ettinger R et al (2004) Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol 173:5361\u20135371","journal-title":"J Immunol"},{"key":"1460_CR18","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nature03555","volume":"435","author":"CG Vinuesa","year":"2005","unstructured":"Vinuesa CG, Cook MC, Angelucci C et al (2005) A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435:452\u2013458","journal-title":"Nature"},{"issue":"11","key":"1460_CR19","first-page":"1041","volume":"23","author":"XF Wang","year":"2007","unstructured":"Wang XF, Yuan SL, Jiang L et al (2007) Changes of serum BAFF and IL-21 levels in patients with systemic lupus erythematosus and their clinical significance. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 23(11):1041\u20131042 Chinese","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"issue":"1","key":"1460_CR20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10875-009-9325-5","volume":"30","author":"CK Wong","year":"2010","unstructured":"Wong CK, Wong PT, Tam LS et al (2010) Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity. J Clin Immunol 30(1):45\u201352","journal-title":"J Clin Immunol"},{"issue":"10","key":"1460_CR21","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3899\/jrheum.100259","volume":"37","author":"TK Rasmussen","year":"2010","unstructured":"Rasmussen TK, Andersen T, Hvid M et al (2010) Increased interleukin 21 (IL-21) and IL-23 are associated with increased disease activity and with radiographic status in patients with early rheumatoid arthritis. J Rheumatol 37(10):2014\u20132020","journal-title":"J Rheumatol"},{"issue":"5","key":"1460_CR22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","volume":"8","author":"MN Meriggioli","year":"2009","unstructured":"Meriggioli MN, Sanders DB (2009) Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 8(5):475\u2013490","journal-title":"Lancet Neurol"},{"issue":"1","key":"1460_CR23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","volume":"335","author":"AE Coutinho","year":"2011","unstructured":"Coutinho AE, Chapman KE (2011) The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol 335(1):2\u201313","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"1460_CR24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.imlet.2010.03.009","volume":"131","author":"CM Spies","year":"2010","unstructured":"Spies CM, Gaber T, Hahne M et al (2010) Rimexolone inhibits proliferation, cytokine expression and signal transduction of human CD4+ T-cells. Immunol Lett 131(1):24\u201332","journal-title":"Immunol Lett"},{"issue":"1","key":"1460_CR25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4049\/jimmunol.1002485","volume":"186","author":"G Stary","year":"2011","unstructured":"Stary G, Klein I, Bauer W et al (2011) Glucocorticosteroids modify Langerhans cells to produce TGF-\u03b2 and expand regulatory T cells. J Immunol 186(1):103\u2013112","journal-title":"J Immunol"},{"key":"1460_CR26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2172-9-47","volume":"9","author":"M Momcilovi\u0107","year":"2008","unstructured":"Momcilovi\u0107 M, Miljkovi\u0107 Z, Popadi\u0107 D et al (2008) Methylprednisolone inhibits interleukin-17 and interferon-gamma expression by both naive and primed T cells. BMC Immunol 9:47","journal-title":"BMC Immunol"},{"issue":"5","key":"1460_CR27","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/art.20218","volume":"50","author":"A J\u00fcngel","year":"2004","unstructured":"J\u00fcngel A, Distler JH, Kurowska-Stolarska M et al (2004) Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with\u00a0rheumatoid arthritis. Arthritis Rheum 50(5):1468\u20131476","journal-title":"Arthritis Rheum"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-013-1460-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-013-1460-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-013-1460-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:19:53Z","timestamp":1559121593000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-013-1460-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,26]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["1460"],"URL":"https:\/\/doi.org\/10.1007\/s10072-013-1460-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,26]]}}}